Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-07-04
2006-07-04
Saeed, Kamal A. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S126000
Reexamination Certificate
active
07071209
ABSTRACT:
The invention relates to a process for preparing granisetron, or a pharmaceutically acceptable salt thereof, which comprises: a) cyclisation of a compound of formula (I) in an inert solvent and at a temperature between 0–100° C., in the presence of a strong acid, in order to yield the compound of formula (II); b) methylation of the compound of formula (II), with an alkylating agent, in the presence of a base, in an inert solvent and at a temperature between 0° C.–160° C., and with optional formation of a pharmaceutically acceptable salt. The process of the invention yields a granisetron of high purity, preventing impurities due to demethylation, by carrying out the methylation after rather than before cyclisation and with a higher yield.
REFERENCES:
patent: 0200444 (1986-11-01), None
patent: 2129349 (1997-02-01), None
patent: 9523799 (1995-09-01), None
patent: 9730049 (1997-08-01), None
Barjoan Pere Dalmases
Puig Torres Salvador
Laboratorios Vita, S.A.
Saeed Kamal A.
Wolf Block Schorr & Solis-Cohen LLP
LandOfFree
Process for preparing a pharmaceutically active compound... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Process for preparing a pharmaceutically active compound..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Process for preparing a pharmaceutically active compound... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3589844